Apoptosis, cell proliferation and modulation of cyclin-dependent kinase inhibitor p21cip1 in vascular remodelling during vein arterialization in the rat

International Journal of Experimental Pathology

Volumn 90, Issue 3, 2009, Pages 328-337

  Borin, Thaiz Ferraz ^a   Miyakawa, Ayumi Aurea ^a   Cardoso, Leandro ^a   De Figueiredo Borges, Luciano ^a   Gonçalves, Giovana Aparecida ^a   Krieger, Jose Eduardo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Animal model; Vein graft; Venous arterialization

Indexed keywords

ALPHA ACTIN; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN DEPENDENT KINASE INHIBITOR 2A;

ADAPTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTERY MEDIA; ARTICLE; CAROTID ARTERY; CELL DENSITY; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; HEART MUSCLE CONTRACTILITY; IMMUNOHISTOCHEMISTRY; INTIMA; JUGULAR VEIN; MODULATION; MORPHOLOGY; MORPHOMETRICS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; REVASCULARIZATION; SMOOTH MUSCLE FIBER; TRANSMISSION ELECTRON MICROSCOPY; VALIDATION PROCESS; VASCULAR PATENCY; VASCULARIZATION; VEIN; VEIN GRAFT;

ACTINS; ANIMALS; APOPTOSIS; ARTERIOVENOUS SHUNT, SURGICAL; CAROTID ARTERY, COMMON; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR PROTEINS; IN SITU NICK-END LABELING; JUGULAR VEINS; MICROSCOPY, ELECTRON; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, WISTAR;

EID: 65549102164     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2009.00648.x     Document Type: Article

References (33)

1. Bond M., Sala-Newby G.B., Wu Y.J., Newby A.C. (2006) Biphasic effect of p21Cip1 on smooth muscle cell proliferation: role of PI 3-kinase and Skp2-mediated degradation. Cardiovasc. Res. 69, 198 206. (Pubitemid 41818971)
2. Bourassa M.G., Campeau L., Lespérance J., Solymoss B.C. (1986) Atherosclerosis after coronary artery bypass surgery: results of recent studies and recommendations regarding prevention. Cardiology 73, 259 268. (Pubitemid 16035716)
3. Brower G.L. Janicki J.S. (2001) Contribution of ventricular remodeling to pathogenesis of heart failure in rats. Am. J. Physiol. Heart Circ. Physiol. 280, H674 H683. (Pubitemid 32466910)
4. Chang M., Barr E., Lu M., Barton K., Leiden J. (1995) Adenovirus-mediated overexpression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular SMC proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. J. Clin. Invest. 96, 2260 2268.
5. Chen D., Krasinki K., Chen D., Sylvester A., Nisen P.D., Andres V. (1997) Down-regulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in VSMC by p27, an inhibitor of neointima formation in the rat carotid artery. J. Clin. Invest. 99, 2334 2341. (Pubitemid 27227709)
6. Dotto G.P. (2000) p21(WAF1/Cip1): more than a break to the cell cycle? Biochim. Biophys. Acta 1471, M43 M56.
7. Ducoux M., Urbach S., Baldacci G. et al. (2001) Mediation of proliferating cell nuclear antigen (PCNA)-dependent DNA replication through a conserved p21(Cip1)-like PCNA-binding motif present in the third subunit of human DNA polymerase delta. J. Biol. Chem. 276, 49258 49266. (Pubitemid 37370636)
8. Gallo R., Padurean A., Jayaraman T. et al. (1999) Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Circulation 99, 2164 2170. (Pubitemid 29196802)
9. Kwei S., Stavrakis G., Takahas M. et al. (2004) Early adaptive responses of the vascular wall during venous arterialization in mice. Am. J. Pathol. 164, 81 89. (Pubitemid 38364593)
10. Liu S.Q. Fung Y.C. (1998) Changes in the organization of the smooth muscle cells in the rat vein graft. Ann. Biomed. Eng. 26, 86 95. (Pubitemid 128609792)
11. Liu S.Q., Moore M.M., Yap C. (2000) Prevention of mechanical stretch-induced endothelial and smooth muscle cell injury in experimental vein grafts. J. Biomech. Eng. 122, 31 38. (Pubitemid 30204699)
12. Mehta D., Izzat M.B., Bryan A.J., Angelini G.D. (1997) Towards the prevention of vein graft failure. Int. J. Cardiol. 62, S55 S63. (Pubitemid 27523597)
13. Moore M.M., Goldman J., Patel A.R., Chien S., Liu S.Q. (2001) Role of tensile stress and strain in the induction of cell death in experimental vein grafts. J. Biomech. 34, 289 297. (Pubitemid 32140990)
14. Nath K.A., Kanakiriya S.K., Grande J.P., Croatt A.J., Katusic Z.S. (2003) Increased venous proinflammatory gene expression and intimal hyperplasia in an aorto-caval fistula model in the rat. Am. J. Pathol. 162, 2079 2090. (Pubitemid 36613063)
15. Neukamm B., Miyakawa A.A., Fukada S.Y. et al. (2008) Local TAT-p27kip1 fusion protein inhibits cell proliferation in rat carotid arteries. Ther. Adv. Cardiovasc. Dis. 2, 129 136.
16. Owens G.K. (1995) Regulation of differentiation of vascular smooth muscle cells. Physiol. Rev. 75, 487 517.
17. Pieruzzi F., Abassi Z.A., Keiser H.R. (1995) Expression of renin-angiotensin system components in the heart, kidneys, and lungs of rats with experimental heart failure. Circulation 92, 3105 3112.
18. Podust V.N., Podust L.M., Goubin F., Ducommun B., Hübscher U. (1995) Mechanism of inhibition of proliferating cell nuclear antigen-dependent DNA synthesis by the cyclin-dependent kinase inhibitor p21. Biochemistry 34, 8869 8875.
19. Rodriguez E., Lambert E.H., Magno M.G., Mannion J.D. (2000) Contractile smooth muscle cell apoptosis early after saphenous vein grafting. Ann. Thorac. Surg. 70, 1145 1153.
20. Ruzicka M. Leenen F.H. (1995) Relevance of blockade of cardiac and circulatory angiotensin-converting enzyme for the prevention of volume overload-induced cardiac hypertrophy. Circulation 91, 16 19.
21. Sherr C.J. Roberts J.M. (1999) CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501 1512. (Pubitemid 29297917)
22. Tanner F.C., Yang Z.Y., Duckers E., Gordon D., Nabel G.J., Nabel E.G. (1998) Expression of cyclin-dependent kinase inhibitors in vascular disease. Circ. Res. 82, 396 403. (Pubitemid 28101197)
23. Tanner F.C., Boehm M., Akyürek L.M. et al. (2000) Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation. Circulation 101, 2022 2025. (Pubitemid 30233162)
24. Torsney E., Mayr U., Zou Y., Thompson W.D., Hu Y., Xu Q. (2004) Thrombosis and neointima formation in vein grafts are inhibited by locally applied aspirin through endothelial protection. Circ. Res. 94, 1466 1473. (Pubitemid 38780319)
25. Tsui L.V., Camrud A., Mondesire J. et al. (2001) p27-p16 fusion gene inhibits angioplasty-induced neointimal hyperplasia and coronary artery occlusion. Circ. Res. 89, 323 328. (Pubitemid 34132670)
26. Verma S., Szmitko P.E., Weisel R.D. et al. (2004) Should radial arteries be used routinely for coronary artery bypass grafting? Circulation 110, e40 e46.
27. Waga S., Hannon G.J., Beach D., Stillman B. (1994) The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369, 574 578. (Pubitemid 24192528)
28. Weiss R.H., Joo A., Randour C. (2000) p21(Waf1/Cip1) is an assembly factor required for platelet-derived growth factor-induced vascular smooth muscle cell proliferation. J. Biol. Chem. 275, 10285 10290. (Pubitemid 30202086)
29. Westerband A., Crouse D., Richter L.C. et al. (2001) Vein adaptation to arterialization in an experimental model. J. Vasc. Surg. 33, 561 569. (Pubitemid 32215607)
30. Wilkins M.R., Settle S.L., Stockmann P.T., Needleman P. (1990) Maximizing the natriuretic effect of endogenous atriopeptin in a rat model of heart failure. Proc. Natl. Acad. Sci. U.S.A. 87, 6465 6469. (Pubitemid 20259039)
31. Zhang L., Peppel K., Brian L., Chien L., Freedman N.J. (2004) Vein graft neointimal hyperplasia is exacerbated by tumor necrosis factor receptor-1 signaling in graft-intrinsic cells. Arterioscler. Thromb. Vasc. Biol. 24, 2277 2283. (Pubitemid 39658029)
32. Zhang L., Sivashanmugam P., Wu J.H. et al. (2008) Tumor necrosis factor receptor-2 signaling attenuates vein graft neointima formation by promoting endothelial recovery. Arterioscler. Thromb. Vasc. Biol. 28, 284 289.
33. Zou Y., Dietrich H., Hu Y., Metzler B., Wick G., Xu Q. (1998) Mouse model of venous bypass graft arteriosclerosis. Am. J. Pathol. 153, 1301 1310. (Pubitemid 28465854)